Lerapolturev in Recurrent Malignant Glioma

Clinical trial NCT02986178 · COMPLETED

Trial details

NCT number: NCT02986178
Sponsor: Istari Oncology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Glioma

Start date: 2017-06-01
Primary completion: 2022-09-30
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.